Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials
- 1 November 2017
- journal article
- research article
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 35 (5) , 529-535
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inositol as putative integrative treatment for PCOSReproductive BioMedicine Online, 2016
- The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysisHuman Reproduction, 2016
- Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOSEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2015
- Potential role and therapeutic interests of myo-inositol in metabolic diseasesBiochimie, 2013
- The combined therapy myo-inositol plus d-chiro-inositol, rather than d-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trialArchives of Gynecology and Obstetrics, 2013
- Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized studyGynecological Endocrinology, 2013
- CONCERN: Does ovary need D-chiro-inositol?Journal of Ovarian Research, 2012
- The D-chiro-inositol paradox in the ovaryFertility and Sterility, 2011
- The Istanbul consensus workshop on embryo assessment: proceedings of an expert meetingHuman Reproduction, 2011
- Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte qualityHuman Reproduction, 2002